TLS Advisors LLC
- SEC CIK
- 0001768824
- Latest filing
- Aug 14, 2026
OVID holding history
Ovid Therapeutics Inc. in every 13F filed by TLS Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OVID overviewAll 13F holders of OVIDFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,858
- Value
- $50.7K
- % of portfolio
- 0.1%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,858 | $50.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 18,858 | $41.0K | 0.1% | +5,258+38.7% | Added | Holders |
| Q4 2025 | 13,600 | – | – | −5,258−27.9% | Reduced | Holders |
| Q3 2025 | 18,858 | $26.0K | 0.1% | −662,109−97.2% | Reduced | Holders |
| Q2 2025 | 680,967 | $225.0K | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 680,967 | $213.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 680,967 | $636.0K | 1.5% | −90,564−11.7% | Reduced | Holders |
| Q3 2024 | 771,531 | $910.0K | 1.9% | −353,765−31.4% | Reduced | Holders |
| Q2 2024 | 1,125,296 | $866.0K | 2.2% | −194,383−14.7% | Reduced | Holders |
| Q1 2024 | 1,319,679 | $4.03M | 9.9% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,319,679 | $4.25M | 14.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,319,679 | $5.07M | 20.5% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,319,679 | $4.33M | 18.6% | −60,667−4.4% | Reduced | Holders |
| Q1 2023 | 1,380,346 | $3.52M | 18.1% | −110,188−7.4% | Reduced | Holders |
| Q4 2022 | 1,490,534 | $2.77M | 13.7% | – | No prior filing | Holders |